IUPAC Name: 18-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-m
EC Number: 691-729-9
Molecular Weight: 4114
Chemical Formula: C₁₈₇H₂₉₁N₄₅O₅₉
CAS Number: 910463-68-2

Autres informations

Description supplémentaire:

This pharmaceutical-grade Semaglutide (CAS 910463-68-2), supplied but not manufactured by Rocktech Pharmaceutical, is a long-acting GLP-1 receptor agonist polypeptide API presented as a white to almost-white powder requiring frozen storage at -20°C under a cold chain, offered at mainstream purities of 98-99.5% by HPLC via solid-phase chemical synthesis incorporating the non-natural amino acid Aib. The supplier positions it for type 2 diabetes, obesity/weight management, and cardiovascular risk reduction, suited to generic ANDA filings, formulation development, and research, available in injectable (once-weekly) and oral tablet forms referencing the original Novo Nordisk product. It is distributed across North America, Europe, Asia, the Middle East, and Africa.